Form 4 for CGEM Cullinan Therapeutics, Inc.
Accepted 2025-02-27 00:00:00 ET · period of report 2025-02-25 · accession 0000950170-25-029201 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-27 | 2025-02-25 | CGEM | Jones Jeffrey Alan | Chief Medical Off | S - Sale | $8.53 | -4,895 | 174.2K | -3% | -$41.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-02-25 | S | D | 4,895 | $8.53 | 174,164 | D | — | — | (F1) Sale of shares to cover personal income tax obligations upon vesting of restricted stock units. |